Timeline
Creo Medical
Creo Medical lifts FY26 revenue growth guidance after first-quarter jump
Creo to sell 49% stake in its Creo Medical business
Creo Medical to raise £5.5m in placing to fund growth
Creo Medical device used in novel BEAM bariatric procedures by US pioneer
Creo Medical sees sharp rise Q1 revenue
More in Medtech & Diagnostics
GENinCode genetic test cuts cardiac risk in Catalonia pilot
A real-world pilot by Catalonia's health service found GENinCode's CARDIO inCode-Score reclassified risk in over 40% of moderate-risk patients and drove measurable improvements in cholesterol and smoking cessation.